Exane Derivatives’s iShares S&P Small-Cap 600 Value ETF IJS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$19.2K Hold
216
0.01% 366
2022
Q1
$22.1K Buy
216
+22
+11% +$2.24K 0.01% 655
2021
Q4
$20.3K Buy
194
+23
+13% +$2.41K ﹤0.01% 575
2021
Q3
$17.2K Hold
171
﹤0.01% 692
2021
Q2
$17.5K Sell
171
-1,086
-86% -$114K ﹤0.01% 719
2021
Q1
$127K Buy
+1,257
New +$119K 0.04% 382

Other funds holding IJS

Exane Derivatives's IJS Position: Q2 2022 in Review

Exane Derivatives held its iShares S&P Small-Cap 600 Value ETF (IJS) position steady in Q2 2022 at 216 shares worth $19.2K. The position accounts for 0.01% of the portfolio, ranked #366.

Exane Derivatives first reported a position in IJS in Q1 2021 and has held it in 6 quarters since. The position peaked at $127K in Q1 2021. 793 funds tracked by Wall St. Rank hold IJS as of Q2 2022.

  • Exane Derivatives held 216 shares of iShares S&P Small-Cap 600 Value ETF worth $19.2K as of Q2 2022.
  • Exane Derivatives left its iShares S&P Small-Cap 600 Value ETF share count unchanged in Q2 2022.
  • iShares S&P Small-Cap 600 Value ETF made up 0.01% of Exane Derivatives's portfolio in Q2 2022, its #366 holding.
  • Exane Derivatives first reported a position in iShares S&P Small-Cap 600 Value ETF in Q1 2021 and has held it in 6 quarters since.
  • Exane Derivatives's iShares S&P Small-Cap 600 Value ETF position peaked at $127K in Q1 2021.
  • 793 funds tracked by Wall St. Rank held iShares S&P Small-Cap 600 Value ETF as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.